OPTAFLU

Reason for request

Clinical Benefit

Substantial

The actual benefit of OPTAFLU is substantial.

Clinical Added Value

no clinical added value

In view of the available data, the Transparency Committee considers that the OPTAFLU vaccine does not offer any improvement in actual benefit (IAB V, non-existent) in the prophylaxis of influenza in populations aged over 18 years and covered by the High Council for Public Health guidelines.